UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer

International journal of cancer, 2020-11, Vol.147 (9), p.2515-2525

2020

Volltextzugriff (PDF)

Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer

Scientific reports, 2021-02, Vol.11 (1), p.3388-11, Article 3388

2021

Volltextzugriff (PDF)

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer

Molecular oncology, 2024-08, Vol.18 (8), p.2042-2059

2024

Volltextzugriff (PDF)

Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation

Proceedings of the National Academy of Sciences - PNAS, 2021-11, Vol.118 (45), p.1

2021

Volltextzugriff (PDF)

TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance

Clinical cancer research, 2014-07, Vol.20 (13), p.3569-3580

2014

Volltextzugriff (PDF)

Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease

BMC cancer, 2024-05, Vol.24 (1), p.555-555, Article 555

2024

Volltextzugriff (PDF)

TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer

JNCI : Journal of the National Cancer Institute, 2019-11, Vol.111 (11), p.1202-1215

2019

Volltextzugriff (PDF)

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4662-4670

2017

Volltextzugriff (PDF)

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma

Frontiers in oncology, 2022-04, Vol.12, p.873532-873532

2022

Volltextzugriff (PDF)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer

PloS one, 2015-10, Vol.10 (10), p.e0139965-e0139965

2015

Volltextzugriff (PDF)

Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk

Human mutation, 2017-03, Vol.38 (3), p.265-268

2017

Volltextzugriff (PDF)

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations

Genome medicine, 2018-11, Vol.10 (1), p.92-92, Article 92

2018

Volltextzugriff (PDF)

TP53 Mutations in Breast and Ovarian Cancer

Cold Spring Harbor perspectives in medicine, 2017-01, Vol.7 (1), p.a026252

2017

Volltextzugriff (PDF)

Metabolite profiles in plasma distinguish between patients with periampullary cancer and benign pancreatic disease

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2023-11, Vol.23, p.e111-e111

2023

Volltextzugriff (PDF)

Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells

Genes & development, 2015-06, Vol.29 (12), p.1298-1315

2015

Volltextzugriff (PDF)

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

Cancer research communications, 2022-06, Vol.2 (6), p.434-446

2022

Volltextzugriff (PDF)

Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53

Molecular cancer research, 2015-03, Vol.13 (3), p.493-501

2015

Volltextzugriff (PDF)

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients

Frontiers in genetics, 2016-05, Vol.7, p.85-85

2016

Volltextzugriff (PDF)

Abstract P3-10-03: Exploiting p53-dependent functional duality of estrogen receptor-beta to repurpose tamoxifen for triple negative breast cancer therapy

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-10-03

2020

Volltextzugriff (PDF)

Abstract 3748: p53 status as a determinant of functional duality of estrogen receptor beta in breast cancer: Therapeutic implications

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3748-3748

2018

Volltextzugriff (PDF)

Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases

Oncotarget, 2017-09, Vol.8 (44), p.76290-76304

2017

Volltextzugriff (PDF)

Abstract 2842: Dissecting the transcriptional profiles of metastatic and primary disease across cancer types

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2842-2842

2017

Volltextzugriff (PDF)

Abstract 1752: Immune-related gene signatures in colorectal liver metastases: Exposing an opportunity for immune modulating therapy

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1752-1752

2017

Volltextzugriff (PDF)

Abstract 1813: Bevacizumab potentiates the proteomic response to neoadjuvant chemotherapy in breast cancer patients: Rppa exploration of consecutive tumor samples in the NeoAva randomized phase II trial

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1813-1813

2017

Volltextzugriff (PDF)

Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy

Metabolomics, 2017-04, Vol.13 (4), p.1, Article 37

2017

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(16)
Humans
(14)
Female
(12)
Breast Cancer
(11)
Oncology
(11)
Tumors
(10)
Chemotherapy
(7)
Gene Expression
(7)
Patients
(7)
Bevacizumab
(6)
Breast Neoplasms - Genetics
(6)
Tumor Suppressor Protein P53 - Genetics
(6)
Breast Neoplasms - Pathology
(5)
Cancer
(5)
Prognosis
(5)
Adult
(4)
Angiogenesis
(4)
Cell Biology
(4)
Genetics & Heredity
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer

Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer

Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation

TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance

Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease

TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer

Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations

TP53 Mutations in Breast and Ovarian Cancer

Metabolite profiles in plasma distinguish between patients with periampullary cancer and benign pancreatic disease

Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells

Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients

Abstract P3-10-03: Exploiting p53-dependent functional duality of estrogen receptor-beta to repurpose tamoxifen for triple negative breast cancer therapy

Abstract 3748: p53 status as a determinant of functional duality of estrogen receptor beta in breast cancer: Therapeutic implications

Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases

Abstract 2842: Dissecting the transcriptional profiles of metastatic and primary disease across cancer types

Abstract 1752: Immune-related gene signatures in colorectal liver metastases: Exposing an opportunity for immune modulating therapy

Abstract 1813: Bevacizumab potentiates the proteomic response to neoadjuvant chemotherapy in breast cancer patients: Rppa exploration of consecutive tumor samples in the NeoAva randomized phase II trial

Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy

Suchergebnisse filtern